Navigation Links
DURECT Corporation to Participate in Upcoming Healthcare Conferences
Date:6/6/2008

CUPERTINO, Calif., June 6 /PRNewswire-FirstCall/ -- DURECT Corporation (Nasdaq: DRRX) announced today that management is scheduled to present at three upcoming life sciences conferences in New York, NY.
-- Needham & Company's Biotechnology and Medical Technology Conference on

Thursday, June 12th at 11:30 a.m. EDT.

-- Leerink Swann's Pain Roundtable Conference, on Monday, June 23rd at

12:45 p.m. EDT.

-- Jefferies' 2nd Annual Healthcare Conference on Thursday, June 26th at

10:45 a.m. EDT.

A live audio webcast of the presentations will be available by accessing DURECT's homepage at http://www.durect.com and clicking "Investor Relations." If you are unable to participate during the live webcast, the call will be archived on DURECT's website under Audio Archive in the "Investor Relations" section.

About DURECT Corporation

DURECT Corporation is an emerging specialty pharmaceutical company developing pharmaceutical systems based on its proprietary drug delivery platform technologies. The Company currently has a number of late-stage pharmaceutical products in development addressing large markets in pain management, with a number of research programs underway targeting chronic disease and other therapeutic areas. For more information, please visit http://www.durect.com.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020717/DRRXLOGO)


'/>"/>
SOURCE DURECT Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. DURECT Corporation Announces Fourth Quarter and Year End 2007 Financial Results
2. DURECT Corporation Invites You to Join Its Fourth Quarter 2007 Earnings Conference Call
3. DURECT to Host Webcast in Conjunction with an Analysts Day on October 17
4. DURECT Corporation to Present at the NewsMakers in the Biotech Industry Investment Conference
5. CEL-SCI CORPORATION Manufacturing Facility for Pivotal Phase III Cancer Trial Scheduled to Be Completed During 2008 Third Quarter
6. Oxford Finance Corporation and ATEL Ventures, Inc. Provide $7.5 Million Venture Loan to AxoGen, Inc.
7. Kendle Expands Global Clinical Pharmacology Capabilities with Acquisition of DecisionLine Clinical Research Corporation
8. David M. Stout Joins NanoBio Corporations Board of Directors
9. CellCyte Genetics Corporation Announces Launch of Comprehensive Web site Powered by PRNewswire Investor Room Backend Technology
10. BioElectronics Corporation - Substantial International Expansion Producing Sustained Revenue Growth-Company Reaches Monthly Break Even
11. Digirad Corporation Signs Letter of Understanding With Johns Hopkins University School of Medicine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/18/2017)... , ... July 18, 2017 , ... ... accelerate pharmaceutical and biotherapeutics development, announces the launch of a new NTA biosensor ... chip enables researchers to study the kinetics of polyhistidine-tagged (His-tagged) molecules quickly and ...
(Date:7/18/2017)... ... July 18, 2017 , ... Genedata, a leading provider ... and technology company, has implemented Genedata Biologics ™ to scale-up their bispecific ... Immunology, and Neurodegenerative Diseases. , The need to systematically evaluate large panels of ...
(Date:7/18/2017)... Antonio, Texas (PRWEB) , ... July 18, 2017 , ... ... can affect patients across the region. Nationally, summer is a struggle for community blood ... is why the San Antonio Chamber of Commerce is teaming up with ...
(Date:7/18/2017)... ... 18, 2017 , ... Recently recognized by CIO Magazine as ... migration of its flagship cloud-based product Planet Life Cycle – a robust work ... system that merges strategic and financial planning with execution. The solution is leveraged ...
Breaking Biology Technology:
(Date:4/5/2017)... April 4, 2017 KEY FINDINGS ... expand at a CAGR of 25.76% during the forecast ... the primary factor for the growth of the stem ... https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global stem cell ... application, and geography. The stem cell market of the ...
(Date:4/3/2017)... , April 3, 2017  Data captured ... engineering platform, detected a statistically significant association ... prior to treatment and objective response of ... potential to predict whether cancer patients will ... treatment, as well as to improve both pre-infusion ...
(Date:3/30/2017)... HONG KONG , March 30, 2017 ... developed a system for three-dimensional (3D) fingerprint identification by adopting ground ... technology into a new realm of speed and accuracy for use ... applications at an affordable cost. ... ...
Breaking Biology News(10 mins):